全文获取类型
收费全文 | 465篇 |
免费 | 9篇 |
国内免费 | 34篇 |
专业分类
儿科学 | 16篇 |
妇产科学 | 1篇 |
基础医学 | 46篇 |
口腔科学 | 8篇 |
临床医学 | 42篇 |
内科学 | 50篇 |
皮肤病学 | 6篇 |
神经病学 | 20篇 |
特种医学 | 170篇 |
外科学 | 36篇 |
综合类 | 19篇 |
预防医学 | 34篇 |
眼科学 | 11篇 |
药学 | 29篇 |
中国医学 | 2篇 |
肿瘤学 | 18篇 |
出版年
2022年 | 2篇 |
2020年 | 1篇 |
2019年 | 1篇 |
2018年 | 3篇 |
2017年 | 2篇 |
2016年 | 3篇 |
2015年 | 10篇 |
2014年 | 10篇 |
2013年 | 8篇 |
2012年 | 7篇 |
2011年 | 12篇 |
2010年 | 19篇 |
2009年 | 36篇 |
2008年 | 25篇 |
2007年 | 30篇 |
2006年 | 29篇 |
2005年 | 30篇 |
2004年 | 13篇 |
2003年 | 11篇 |
2002年 | 16篇 |
2001年 | 16篇 |
2000年 | 4篇 |
1999年 | 18篇 |
1998年 | 27篇 |
1997年 | 33篇 |
1996年 | 20篇 |
1995年 | 11篇 |
1994年 | 9篇 |
1993年 | 12篇 |
1992年 | 7篇 |
1991年 | 4篇 |
1990年 | 6篇 |
1989年 | 13篇 |
1988年 | 18篇 |
1987年 | 7篇 |
1986年 | 8篇 |
1985年 | 6篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1981年 | 5篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1975年 | 3篇 |
排序方式: 共有508条查询结果,搜索用时 15 毫秒
101.
目的:分析血管紧张素原基因启动子区A-20C和A-6G单核苷酸多态性与蒙古族人群原发性高血压的相关性。方法:实验于2005-08/2006-01在北京华大实验室完成。选取对象均为生活在内蒙古乌拉特后旗的蒙古族牧民,三代血亲内无其他民族。采用基因测序技术对内蒙古蒙古族人群中107例原发性高血压患者和108例正常对照者进行A-20C和A-6G基因分型,观察高血压组和正常对照组不同基因型的分布和等位基因频率的差异。结果:①两组受试者在性别、年龄及吸烟、饮酒、体质量指数和临床化验检查指标有较好的匹配(P均>0.05)。②两组血管紧张素原基因A-20C位点AA,AC,CC基因型频率比较差异无显著性意义(高血压组分别为0.51,0.29,0.20;正常对照组分别为0.49,0.28,0.23,χ2=0.395,P=0.529)。A,C等位基因频率比较差异无显著性意义(高血压组分别为0.65,0.35;正常对照组分别为0.63,0.37,χ2=0.015,P=0.904)。③两组血管紧张素原基因A-6G位点AA,AG,GG基因型频率比较差异无显著性意义(高血压组分别为0.50,0.33,0.17;正常对照组分别为0.55,0.34,0.11,χ2=1.924,P=0.165)。A,G等位基因频率比较差异无显著性意义(高血压组分别为0.66,0.34;正常对照组分别为0.72,0.28,χ2=1.728,P=0.189)。④高血压组协同存在血管紧张素原基因A-20C基因型CC时,血管紧张素原基因A-6G基因型GG频率稍高于正常对照组,但差异无显著性意义(χ2=2.395,P=0.122,OR=7.52,95%CI0.014~1.250),高血压组G等位基因明显高于正常对照组(分别为0.37,0.22,χ2=4.658,P=0.034),携带该等位基因的蒙古族人群发生原发性高血压的相对危险度升高(OR=2.80,95%CI1.087~7.271)。结论:血管紧张素原基因A-20C和A-6G单核苷酸多态性与蒙古族人群原发性高血压相关,并可能具有协同作用。 相似文献
102.
PK Tran A Haworth F Foroudi A Paneghel AG Herschtal KH Tai SG Williams S Soteriou M Laferlita GM Duchesne 《Journal of Medical Imaging and Radiation Oncology》2009,53(6):574-580
The aim of this study is to prospectively evaluate and model surrogate explanatory variables (SEVs) of target coverage and rectal dose pertaining to soft tissue anatomy visualised on cone beam computed tomography (CBCT) for incorporation into post‐prostatectomy treatment coverage verification protocols. Twenty post‐prostatectomy patients treated with conformal prostate bed radiotherapy (64–74 Gy) underwent CBCT daily at fractions 1 to 5, and then weekly. Treatment coverage was defined on each CBCT using ‘PTV95’, percentage of the CBCT PTV covered by original treatment fields, and ‘RECTD50’, dose delivered to 50% of CBCT rectal volume by original treatment fields. Three candidate SEVs for treatment coverage were defined for each scan: anterior rectal wall movement, change in bladder length and bladder base movement. Both anterior rectal wall movement and increase in bladder length predicted for the decreased PTV95 (P < 0.001 for each). Anterior movement of the anterior rectal wall predicted for increased RECTD50 (P < 0.001). Predictive models for the PTV95 and RECTD50 that accept the significant SEVs as inputs were developed. We developed simple CBCT‐acquired soft tissue anatomic surrogate measures that signal changes in target coverage and rectal dose during post‐prostatectomy radiotherapy. Conventional bony anatomy patient position verification protocols were inadequate in accounting for soft tissue target and organ variation seen with CBCT. 相似文献
103.
目的研究曲安奈德(TA)辅助玻璃体切割手术在临床的应用价值。方法28例(29只眼)于2004年1月~2004年12月行玻璃体切割术,术中注入已过滤的TA悬浮液0.1ml(40mg/m1),以帮助辨认玻璃体后皮质、视网膜前增殖膜、黄斑前膜、内界膜,9例硅油填充,7例C3FR(15%)填充。手术后17例随访6个月以上,11例随访3至4个月。结果所有的病例,经TA注入后,可明显的改善玻璃体后皮质、视网膜前膜、内界膜的辨认情况。糖尿病视网膜病变术后视力提高占61.5%,伴PVR的视网膜脱离术后视力提高占61.3%,黄斑裂孔4例中3例术后视力提高,4例黄斑前膜术后视力均有提高。所有28例均没有出现高眼压。8例伴PVR的视网膜脱离中6例(占75%)视网膜复位,4例黄斑裂孔均关闭,2例糖尿病黄斑水肿手术后明显减轻。结论经过滤的TA可作为玻璃体切割手术中较好的辅助工具,TA悬浮液是呈白色胶样,可粘附于玻璃体皮质、视网膜前膜或内界膜,帮助分辨玻璃体后皮质、视网膜前膜、内界膜,提高手术效率。没有发现与TA有关的副作用。 相似文献
104.
Evidence for endogenous formation of tobacco-specific nitrosamines in rats treated with tobacco alkaloids and sodium nitrite 总被引:2,自引:0,他引:2
Carcinogenic tobacco-specific nitrosamines are present in tobacco products
and are believed to play a significant role in human cancers associated
with tobacco use. Additional amounts of tobacco-specific nitrosamines could
be formed endogenously. We tested this hypothesis by treating rats with
nicotine and sodium nitrite and analyzing their urine. Initially, we
treated groups of rats with (S)-nicotine (60 micromol/kg) and NaNO2 (180
micromol/kg), (S)-nicotine alone, NaNO2 alone or
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK, 12 nmol/kg) by gavage
twice daily for 4 days. We collected urine and analyzed for two metabolites
of NNK; 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol and its glucuronide.
We did not detect these metabolites in the urine of rats treated with
nicotine alone or nicotine plus NaNO2, indicating that endogenous
conversion of nicotine to NNK did not occur. However, the urine did contain
N'- nitrosonornicotine (NNN), N'-nitrosoanabasine (NAB) and N'-
nitrosoanatabine (NAT). Analysis of the (S)-nicotine used in this
experiment demonstrated that it contained trace amounts of nornicotine,
anabasine and anatabine. In a second experiment, we used an identical
protocol to compare the endogenous nitrosation of this (S)-nicotine with
that of synthetic (R,S)-nicotine, which did not contain detectable amounts
of nornicotine, anabasine or anatabine. NNN (0.53 x 10(-3)% of nicotine
dose), NAB (0.68%) and NAT (2.1%) were detected in the urine of the rats
treated with the (S)-nicotine and NaNO2. NNN (0.47 x 10(- 3)% of dose), but
not NAB or NAT, was present in the urine of the rats treated with synthetic
(R,S)-nicotine and NaNO2. NNN probably formed via nitrosation of
metabolically formed nornicotine. These results demonstrate for the first
time that endogenous formation of tobacco- specific nitrosamines occurs in
rats treated with tobacco alkaloids and NaNO2. The potential significance
of the results with respect to nitrosamine formation in people who use
tobacco products or nicotine replacement therapy is discussed.
相似文献
105.
Mark W Tyndall Evan Wood Ruth Zhang Calvin Lai Julio SG Montaner Thomas Kerr 《Harm reduction journal》2006,3(1):36-5
North America's first government sanctioned medically supervised injection facility (SIF) was opened during September 2003
in Vancouver, Canada. This was in response to a large open public drug scene, high rates of HIV and hepatitis C transmission,
fatal drug overdoses, and poor health outcomes among the city's injection drug users. Between December 2003 and April 2005,
a representative sample of 1,035 SIF participants were enrolled in a prospective cohort that required completing an interviewer-administered
questionnaire and providing a blood sample for HIV testing. HIV infection was detected in 170/1007 (17%) participants and
was associated with Aboriginal ethnicity (adjusted Odds Ratio [aOR], 2.70, 95% Confidence Interval [95% CI], 1.84–3.97), a
history of borrowing used needles/syringes (aOR, 2.0, 95% CI, 1.37–2.93), previous incarceration (aOR, 1.87, 95% CI, 1.11–3.14),
and daily injection cocaine use (aOR, 1.42, 95% CI, 1.00–2.03). The SIF has attracted a large number of marginalized injection
drug users and presents an excellent opportunity to enhance HIV prevention through education, the provision of sterile injecting
equipment, and a supervised environment to self-inject. In addition, the SIF is an important point of contact for HIV positive
individuals who may not be participating in HIV care and treatment. 相似文献
106.
Brandon DL Marshall Thomas Kerr Chris Livingstone Kathy Li Julio SG Montaner Evan Wood 《Harm reduction journal》2008,5(1):35
Aboriginal people experience a disproportionate burden of HIV infection among the adult population in Canada; however, less
is known regarding the prevalence and characteristics of HIV positivity among drug-using and street-involved Aboriginal youth.
We examined HIV seroprevalence and risk factors among a cohort of 529 street-involved youth in Vancouver, Canada. At baseline,
15 (2.8%) were HIV positive, of whom 7 (46.7%) were Aboriginal. Aboriginal ethnicity was a significant correlate of HIV infection
(odds ratio = 2.87, 95%CI: 1.02 – 8.09). Of the HIV positive participants, 2 (28.6%) Aboriginals and 6 (75.0%) non-Aboriginals
reported injection drug use; furthermore, hepatitis C co-infection was significantly less common among Aboriginal participants
(p = 0.041). These findings suggest that factors other than injection drug use may promote HIV transmission among street-involved
Aboriginal youth, and provide further evidence that culturally appropriate and evidence-based interventions for HIV prevention
among Aboriginal young people are urgently required. 相似文献
107.
108.
Subjects with late-onset Pompe disease (LOPD) typically present as slowly progressive proximal muscle weakness. Respiratory muscle weakness and diaphragmatic paralysis are common features, and may be the initial manifestation of the disease. There is often a poor correlation between the severity of limb and respiratory muscle weakness. Early clinical observations about disproportionate hypercapnia to the respiratory muscular weakness in late-onset Pompe disease were recognized and will be discussed with special reference to blunted respiratory drive, and the connections between early clinical observations, respiratory functional studies and anatomical findings. According to new evidence about blunted respiratory drive in Pompe disease, it is necessary to rethink what is meant by “asymptomatic Pompe disease” and propose a new phenotype with its therapeutic implications. The conceptual model of the mechanisms leading to respiratory failure in this disease could be considered according to these new findings. It may broaden the diagnostic spectrum of the adult forms and warrants a closer interaction between neurologists and pulmonologists. The recognition of this new phenotype of predominant central alveolar hypoventilation in Pompe disease will improve the understanding of the underlying mechanisms of ventilatory failure and could lead to improved future therapeutic strategies. 相似文献
109.
Aranka Anema Evan Wood Sheri D Weiser Jiezhi Qi Julio SG Montaner Thomas Kerr 《Substance abuse treatment, prevention, and policy》2010,5(1):20
Background
Food insufficiency is often associated with health risks and adverse outcomes among marginalized populations. However, little is known about correlates of food insufficiency among injection drug users (IDU). 相似文献110.
We sought to explore the effect of crystal methamphetamine use on the risk of experiencing malnutrition among street-involved
youth in Vancouver, Canada. Risk of malnutrition was defined as being hungry but not having enough money to buy food. Socio-demographic
and drug use factors associated with risk of malnutrition were investigated using univariate and multivariate analysis among
a prospective cohort of street-involved youth known as the At-Risk Youth Study (ARYS). Between September 2005 and December
2006, 509 street-involved youth were enrolled in ARYS, among whom 21% reported being at risk of malnutrition as defined above
in the previous six months. In multivariate analysis, only non-injection crystal methamphetamine was significantly associated
with being at risk of malnutrition among this cohort (Adjusted Odds Ratio [AOR] = 1.60, 95% Confidence Interval [CI]: 1.03
- 2.48, p = 0.036). Interventions seeking to address food insecurity among street youth may benefit from considering drug use patterns
since methamphetamine use predicted higher risk in this setting. 相似文献